Narinder Pal Bhalla sold $99K of LXEO stock

Narinder Pal Bhalla, Chief Medical Officer of Lexeo Therapeutics, Inc. (LXEO), sold 22,306 shares of LXEO stock worth $99K, per an SEC Form 4 filed Jul 1, 2026.

It was an open-market sale.

The trade happened on Jun 29, 2026, 2 days before it was made public.

LXEO has moved -39.9% since the trade date, from $4.81 to $2.89 (Nov 6, 2026 close).